CLARINEX® Reditabs®
The same allergy fighting strength of
CLARINEX® with the added convenience of a
tablet that breaks up fast.
CLARINEX®
Reditabs® provide the same allergy fighting
strength of CLARINEX® with the added
convenience of a quick disintegrating tablet that can be taken anytime,
anywhere — without water!
The tablet disintegrates rapidly allowing allergy sufferers to
take their medication when it is convenient for them, even when they do not
have access to water. Allergy sufferers who have active lifestyles or dislike
swallowing pills may prefer CLARINEX®
Reditabs® for their allergy treatment.
Options like CLARINEX®
Reditabs® make it possible to identify the
most appropriate allergy treatment for each individual given their lifestyle
and preferences.
CLARINEX® is the only
prescription nonsedating antihistamine approved for patients as young as 6
months old and is available in different forms to accommodate patient
preference and symptoms. The CLARINEX®
family of products includes CLARINEX® (0.5
mg per 1 mL) Syrup for children as young as 6 months old,
CLARINEX®
Reditabs® for both adults and children
starting at 6 years of age and CLARINEX® (5
mg) Tablets and CLARINEX-D® 24 HOUR
(desloratadine 5 mg/pseudoephedrine 240 mg) Extended Release Tablets for
patients 12 years of age and older. CLARINEX-D
24® HOUR combines an antihistamine with a
decongestant for patients suffering from nasal congestion associated with
seasonal allergic rhinitis.
CLARINEX® also is the only
prescription nonsedating, 24-hour antihistamine approved for the treatment of
indoor and outdoor allergies and hives of unknown cause. The efficacy and
safety of CLARINEX® in outdoor allergies has
been established in four double-blind, randomized, placebo-controlled studies
involving more than 2,300 patients with seasonal allergies.
CLARINEX® was also studied in indoor
allergies in two doubleblind, randomized, placebo-controlled studies involving
more than 1,300 patients with perennial allergies. A single 5 mg dose of
CLARINEX® taken once daily provides 24-hour
nonsedating relief from nasal and non-nasal symptoms of indoor and outdoor
allergies. The approval for CLARINEX® in
chronic idiopathic urticaria (CIU) was based on two double-blind, randomized,
placebo-controlled studies involving more than 400 patients.
CLARINEX®, a prescription medication, treats year-round allergy symptoms and ongoing hives of unknown cause, in adults and children 6 months and older, and seasonal allergy symptoms in patients 2 years and older. CLARINEX® 5 mg Tablets and 5 mg RediTabs® Tablets are approved for patients 12 years and older; CLARINEX® 2.5 mg RediTabs® Tablets are approved for patients 6 to 11 years; CLARINEX® Syrup is approved for patients 6 months and older.
Twice-daily CLARINEX-D® 12 HOUR Extended Release Tablets and once-daily CLARINEX-D® 24 HOUR Extended Release Tablets treat the symptoms of seasonal allergies, including nasal congestion, in patients 12 years and older.
IMPORTANT SAFETY INFORMATION
CLARINEX® Tablets side effects in patients 12 years and older were similar to placebo and included sore throat, dry mouth, and fatigue for seasonal and year-round allergy patients, and headache, nausea, and fatigue for patients with ongoing hives of unknown cause.
CLARINEX® Syrup side effects in children 6 to 11 years were similar to placebo. For children 6 months to 5 years, syrup side effects varied by age and included fever, diarrhea, upper respiratory infection, irritability, and coughing.
Due to their pseudoephedrine component, CLARINEX-D® 12 HOUR Extended Release Tablets and CLARINEX-D® 24 HOUR Extended Release Tablets should not be taken by patients with narrow-angle glaucoma (abnormally high eye pressure), difficulty urinating, severe high blood pressure, or severe heart disease, or by patients who have taken a monoamine oxidase (MAO) inhibitor within the past fourteen (14) days. Patients with high blood pressure; diabetes; heart disease; increased intraocular pressure (eye pressure); thyroid, liver or kidney problems; or enlarged prostate should check with their healthcare provider before taking CLARINEX-D® 12 HOUR Extended Release Tablets or CLARINEX-D® 24 HOUR Extended Release Tablets.
Care should be used if CLARINEX-D® 12 HOUR Extended Release Tablets or CLARINEX-D® 24 HOUR Extended Release Tablets are taken with other antihistamines or decongestants because combined effects on the cardiovascular system may be harmful. The most commonly reported adverse events for CLARINEX-D® 12 HOUR Extended Release Tablets were insomnia, headache, dry mouth, fatigue, drowsiness, sore throat, and dizziness. The most commonly reported adverse events for CLARINEX-D® 24 HOUR Extended Release Tablets were dry mouth, headache, insomnia, fatigue, sore throat, and drowsiness.
Click here for important CLARINEX® Tablets/Syrup/RediTabs® Product Information.
Click here for important CLARINEX-D® 12 HOUR Product Information.
Click here for important CLARINEX-D® 24 HOUR Product Information.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Note: The information on this site is not intended to be a substitute for professional medical advice. If you have any questions about your treatment or medical condition, please consult your doctor or other qualified health care provider. This site is intended for use by U.S. residents.
